Insights

Innovative Microbiome Therapies Vedanta Biosciences is developing novel therapies targeting the human microbiome to modulate immune responses, presenting opportunities to collaborate with biotech and pharma companies interested in microbiome-based treatments, personalized medicine, and immune health.

Strategic Industry Partnerships The company's partnerships with major firms like Foxconn and Innolux, along with recent investment from Colorcon Ventures, highlight potential channels for joint development, manufacturing collaborations, and technology licensing in biopharma and biotech sectors.

Recent Funding Activities With a revenue range of up to $100M and recent funding of $3.9M, Vedanta shows potential for growth and investment expansion, making it a promising partner for venture capitalists and institutions seeking innovative biotech solutions.

Market Engagement and Visibility Participation in events such as IDWeek 2024 and investor conferences demonstrates active engagement with the biotech community and investors, offering opportunities for sales teams to connect with key stakeholders and decision-makers in healthcare innovation.

Focus on Autoimmune and Infectious Diseases Vedanta’s focus on microbiome signals related to autoimmune, metabolic, and infectious diseases indicates an open window for sales opportunities in diagnostic tools, clinical research, and therapeutic development targeting these high-demand areas.

Similar companies to Vedanta Biosciences, Inc.

Vedanta Biosciences, Inc. Tech Stack

Vedanta Biosciences, Inc. uses 8 technology products and services including GitHub, Jupyter, jQuery Migrate, and more. Explore Vedanta Biosciences, Inc.'s tech stack below.

  • GitHub
    Communication And Collaboration
  • Jupyter
    File Sharing
  • jQuery Migrate
    Javascript Libraries
  • Microsoft Word
    Office Suites
  • Windows Server
    Operating Systems
  • macOS
    Operating Systems & Computing Languages
  • Yoast SEO
    Search Engines
  • Microsoft Exchange
    Storage

Media & News

Vedanta Biosciences, Inc.'s Email Address Formats

Vedanta Biosciences, Inc. uses at least 1 format(s):
Vedanta Biosciences, Inc. Email FormatsExamplePercentage
FLast@vedantabio.comJDoe@vedantabio.com
45%
First.Last@vedantabio.comJohn.Doe@vedantabio.com
8%
Last@vedantabio.comDoe@vedantabio.com
2%
FLast@vedantabio.comJDoe@vedantabio.com
45%

Frequently Asked Questions

What is Vedanta Biosciences, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Vedanta Biosciences, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Vedanta Biosciences, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Vedanta Biosciences, Inc.'s official website is vedantabio.com and has social profiles on LinkedInCrunchbase.

What is Vedanta Biosciences, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Vedanta Biosciences, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Vedanta Biosciences, Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, Vedanta Biosciences, Inc. has approximately 126 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer, Founder, Board Of Directors: B. O.Chief Medical Officer: J. S.Vice President Of Quality: E. E. A.. Explore Vedanta Biosciences, Inc.'s employee directory with LeadIQ.

What industry does Vedanta Biosciences, Inc. belong to?

Minus sign iconPlus sign icon
Vedanta Biosciences, Inc. operates in the Biotechnology Research industry.

What technology does Vedanta Biosciences, Inc. use?

Minus sign iconPlus sign icon
Vedanta Biosciences, Inc.'s tech stack includes GitHubJupyterjQuery MigrateMicrosoft WordWindows ServermacOSYoast SEOMicrosoft Exchange.

What is Vedanta Biosciences, Inc.'s email format?

Minus sign iconPlus sign icon
Vedanta Biosciences, Inc.'s email format typically follows the pattern of FLast@vedantabio.com. Find more Vedanta Biosciences, Inc. email formats with LeadIQ.

How much funding has Vedanta Biosciences, Inc. raised to date?

Minus sign iconPlus sign icon
As of December 2025, Vedanta Biosciences, Inc. has raised $3.9M in funding. The last funding round occurred on Apr 30, 2024 for $3.9M.

Vedanta Biosciences, Inc.

Biotechnology ResearchMassachusetts, United States51-200 Employees

The trillions of microbes that call us home –the human microbiome – perform critical functions that preserve our health including helping develop our immune system, manufacturing nutrients such as vitamins, and harvesting energy from the diet. Alterations of the human microbiome are increasingly recognized as a key factor in autoimmune, metabolic, infectious and many other diseases.

For millions of years, humans have co-evolved with this community of microbes, communicating in an ancient language that holds critical clues about how autoimmune and infectious diseases develop. This language is based on a system of signals that our resident microbes use to successfully colonize us, such as byproducts of bacterial metabolism and factors that bacteria use to adapt to human niches. Recent discoveries have shown that most of these signals do not lead to disease, rather, they promote our long-term survival.

Vedanta is developing a novel class of therapies that modulate pathways of interaction between the human microbiome and the host immune system. Vedanta was co-founded by PureTech Health and a group of world renowned experts in immunology and microbiology

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $3.9M

    Vedanta Biosciences, Inc. has raised a total of $3.9M of funding over 17 rounds. Their latest funding round was raised on Apr 30, 2024 in the amount of $3.9M.

  • $50M$100M

    Vedanta Biosciences, Inc.'s revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $3.9M

    Vedanta Biosciences, Inc. has raised a total of $3.9M of funding over 17 rounds. Their latest funding round was raised on Apr 30, 2024 in the amount of $3.9M.

  • $50M$100M

    Vedanta Biosciences, Inc.'s revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.